Interim data shows Stelara promise in Crohn’s
admin 14th February 2020 Uncategorised 0Interim data from the Phase IIIb STARDUST study showed that 79% of patients with moderately to severely active Crohn’s disease (CD) achieved clinical response and 67% were in clinical remission.
More: Interim data shows Stelara promise in Crohn’s
Source: News